T. Purendar Reddy , Kishore Karumanchi , Ramadas Chavakula , M. Padma
{"title":"Improved Preparation on Decagram Scale of 5,8-Dihydro-4,6-dihydroxy-5,8-dioxoquinoline-2-carboxylic Acid, a Key Intermediate of Pirenoxine","authors":"T. Purendar Reddy , Kishore Karumanchi , Ramadas Chavakula , M. Padma","doi":"10.1080/00304948.2022.2106107","DOIUrl":null,"url":null,"abstract":"Pirenoxine (Scheme 1, (1)) is a medication used in the treatment and prevention of cataracts. Pirenoxine is sold under the trade name Catalin. Pirenoxine (1) is prepared by the condensation of 5,8-dihydro-4,6-dihydroxy-5,8-dioxoquinoline-2-carboxylic acid (2) with 2-aminophenol in acetic acid as shown in Scheme 1. According to the literature, 5,8-dihydro-4,6-dihydroxy-5,8-dioxoquinoline-2-carboxylic acid (2) is in turn prepared by the oxidation of 4,5,6,8-tetrahydroxyquinoline-2carboxylic acid (4) in the presence of potassium ferricyanide and sulfuric acid in water as shown in Scheme 2 (a). However, the major disadvantage of this synthesis is the use of potassium ferricyanide. Along with the high cost, the reaction between potassium ferricyanide and sulfuric acid may lead to the production of inherently hazardous hydrogen cyanide gas. Hence, this synthesis is not preferable for large scale production. In this context, a facile, economical, safe and industrially viable preparation of 2 has been developed from 4,5,6,8-tetrahydroxyquinoline-2-carboxylic acid (4) under solvent free conditions, and the preparation forms the basis of this report. In our approach, compound 4 is treated with inexpensive ferric chloride with sulfuric acid in water at 20-30 C as shown in Scheme 2 (b) (see Experimental section). On 50 gram scale, the product was obtained in 85% yield as a solid. This method produced a greater yield compared to that of the conventional method (64.5%). During the initial development, several reagents such as chromium trioxide, manganese dioxide, and potassium dichromate had also been tested for this oxidation reaction, but the oxidation reaction of 4 with ferric chloride in aqueous sulfuric acid was superior in forming the desired compound 2. Summing up, this new procedure replaces inherently hazardous and expensive potassium ferricyanide with inexpensive and eco-friendly ferric chloride for the preparation on decagram scale in very good yield of a key intermediate in the synthesis of Pirenoxine.","PeriodicalId":19681,"journal":{"name":"Organic Preparations and Procedures International","volume":"54 6","pages":"Pages 566-568"},"PeriodicalIF":1.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Preparations and Procedures International","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S003049482300062X","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0
Abstract
Pirenoxine (Scheme 1, (1)) is a medication used in the treatment and prevention of cataracts. Pirenoxine is sold under the trade name Catalin. Pirenoxine (1) is prepared by the condensation of 5,8-dihydro-4,6-dihydroxy-5,8-dioxoquinoline-2-carboxylic acid (2) with 2-aminophenol in acetic acid as shown in Scheme 1. According to the literature, 5,8-dihydro-4,6-dihydroxy-5,8-dioxoquinoline-2-carboxylic acid (2) is in turn prepared by the oxidation of 4,5,6,8-tetrahydroxyquinoline-2carboxylic acid (4) in the presence of potassium ferricyanide and sulfuric acid in water as shown in Scheme 2 (a). However, the major disadvantage of this synthesis is the use of potassium ferricyanide. Along with the high cost, the reaction between potassium ferricyanide and sulfuric acid may lead to the production of inherently hazardous hydrogen cyanide gas. Hence, this synthesis is not preferable for large scale production. In this context, a facile, economical, safe and industrially viable preparation of 2 has been developed from 4,5,6,8-tetrahydroxyquinoline-2-carboxylic acid (4) under solvent free conditions, and the preparation forms the basis of this report. In our approach, compound 4 is treated with inexpensive ferric chloride with sulfuric acid in water at 20-30 C as shown in Scheme 2 (b) (see Experimental section). On 50 gram scale, the product was obtained in 85% yield as a solid. This method produced a greater yield compared to that of the conventional method (64.5%). During the initial development, several reagents such as chromium trioxide, manganese dioxide, and potassium dichromate had also been tested for this oxidation reaction, but the oxidation reaction of 4 with ferric chloride in aqueous sulfuric acid was superior in forming the desired compound 2. Summing up, this new procedure replaces inherently hazardous and expensive potassium ferricyanide with inexpensive and eco-friendly ferric chloride for the preparation on decagram scale in very good yield of a key intermediate in the synthesis of Pirenoxine.
期刊介绍:
Organic Preparations and Procedures International (OPPI) publishes important, bimonthly research relevant to organic chemists engaged in synthesis. It is devoted to preparative organic chemistry, organometallic compounds, and procedures generally related to synthesis. The mission has always been to assist the practitioner by publishing reliable and reproducible procedures of the highest standards.
OPPI publishes articles in every area of preparative organic chemistry - from innovative technology to improvements in traditional synthesis. Along with experimental papers, the Journal publishes authoritative reviews on significant topics in synthesis.
The editors work closely with all authors, including those whose first language may not be English, to ensure important work is provided with clarity and a forum, giving OPPI a truly unique opportunity to serve a worldwide audience with valuable material.